| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers K > Headlines for K-V Pharmaceutical Co. > News item |
K-V Pharmaceutical reports $1.6 million of operating income for May
By Jim Witters
Wilmington, Del., June 17 - K-V Pharmaceutical Co. posted operating income of $1.6 million for May on net revenue of $8.77 million, according to the company's monthly operating report filed June 17 with the U.S. Bankruptcy Court for the Southern District of New York.
Those figures compare to a $1.57 million operating loss in April on net revenue of $8.33 million.
The net loss from continuing operations was $3.15 million in May, down from $3.52 million in April.
The company also reported cash and cash equivalents of $38.62 million as of May 31, up from $35.75 million at the end of April.
K-V Pharmaceutical, a St. Louis specialty pharmaceutical company, filed for bankruptcy on Aug. 4, 2012. The Chapter 11 case number is 12-13346.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.